Sign in

CIK 0001701108

  • Non-accelerated filer
  • Smaller reporting company

Spero Therapeutics, Inc.

Sign in to watch
Ticker
SPRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-242-1600
Business address
675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
Former names
Spero Therapeutics, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$42,485
in 1 filing

Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Rajavelu Esther −$42K Reporting owner sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2017-11-06 Goyal Vikas Director Conversion +244,147 244,147
2017-11-06 Goyal Vikas Director Conversion +246,272 490,419
2017-11-06 Goyal Vikas Director Conversion +328,992 819,411
2017-11-06 Goyal Vikas Director Conversion +606,024 1,425,435
2017-11-06 Goyal Vikas Director Purchase +428,571 $14.00 $6.0M 1,854,006
2017-11-06 Goyal Vikas Director Conversion · Junior preferred stock −1,483,784 0
2017-11-06 Goyal Vikas Director Conversion · Series A preferred stock −982,906 0
2017-11-06 Goyal Vikas Director Conversion · Series B preferred stock −1,250,000 0
2017-11-06 Goyal Vikas Director Conversion · Series C preferred stock −3,683,045 0
2017-11-06 Sendek Joel Chief Financial Officer Conversion +10,181 10,181
2017-11-06 Sendek Joel Chief Financial Officer Purchase +5,000 $14.00 $70K 15,181
2017-11-06 Sendek Joel Chief Financial Officer Conversion · Series C Preferred Stock −61,880 0
2017-11-06 Larkin Cristina Chief Operating Officer Purchase +1,500 $14.00 $21K 1,500
2017-11-06 Breum Casper Director Conversion +289,102 289,102
2017-11-06 Breum Casper Director Conversion +179,450 468,552
2017-11-06 Breum Casper Director Conversion +408,937 877,489
2017-11-06 Breum Casper Director Purchase +214,285 $14.00 $3.0M 1,091,774
2017-11-06 Breum Casper Director Conversion · Series A Preferred Stock −1,153,846 0
2017-11-06 Breum Casper Director Conversion · Series B Preferred Stock −681,818 0
2017-11-06 Breum Casper Director Conversion · Series C Preferred Stock −2,485,272 0

Page 17 of 17 · 340 trades